Daniel Brennan
Stock Analyst at TD Cowen
(1.58)
# 2,219
Out of 4,479 analysts
9
Total ratings
41.67%
Success rate
18.38%
Average return
Main Sectors:
Top Industries:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACB Pacific Biosciences of California | Maintains: Buy | $12 → $2.5 | $1.28 | +95.31% | 2 | Apr 17, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.5 | $1.77 | +97.74% | 1 | Apr 16, 2024 | |
| AVTR Avantor | Maintains: Buy | $25 → $29 | $20.58 | +40.91% | 2 | Feb 15, 2024 | |
| TMO Thermo Fisher | Maintains: Overweight | $613 → $670 | $533.93 | +25.48% | 1 | Feb 2, 2023 | |
| CRL Charles River Laboratories International | Upgrades: Buy | n/a | $201.48 | - | 1 | May 13, 2020 | |
| MTD Mettler-Toledo International | Maintains: Neutral | n/a | $1,357.07 | - | 1 | Apr 28, 2020 | |
| EXAS Exact Sciences | Maintains: Buy | n/a | $43.17 | - | 1 | Apr 28, 2020 |
Pacific Biosciences of California
Apr 17, 2024
Maintains: Buy
Price Target: $12 → $2.5
Current: $1.28
Upside: +95.31%
Standard BioTools
Apr 16, 2024
Initiates: Buy
Price Target: $3.5
Current: $1.77
Upside: +97.74%
Avantor
Feb 15, 2024
Maintains: Buy
Price Target: $25 → $29
Current: $20.58
Upside: +40.91%
Thermo Fisher
Feb 2, 2023
Maintains: Overweight
Price Target: $613 → $670
Current: $533.93
Upside: +25.48%
Charles River Laboratories International
May 13, 2020
Upgrades: Buy
Price Target: n/a
Current: $201.48
Upside: -
Mettler-Toledo International
Apr 28, 2020
Maintains: Neutral
Price Target: n/a
Current: $1,357.07
Upside: -
Exact Sciences
Apr 28, 2020
Maintains: Buy
Price Target: n/a
Current: $43.17
Upside: -